Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Free Report) shares gapped up before the market opened on Wednesday . The stock had previously closed at $325.60, but opened at $341.00. Bio-Rad Laboratories shares last traded at $341.00, with a volume of 309 shares trading hands.
Bio-Rad Laboratories Trading Up 4.7 %
The company has a market cap of $9.55 billion, a price-to-earnings ratio of -12.48 and a beta of 0.72. The company’s 50 day moving average price is $334.19 and its 200 day moving average price is $322.81. The company has a debt-to-equity ratio of 0.16, a quick ratio of 4.52 and a current ratio of 6.14.
Bio-Rad Laboratories Company Profile
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
See Also
- Five stocks we like better than Bio-Rad Laboratories
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Consumer Staples Stocks, Explained
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
